Stocks
AnaptysBio (ANAB) CAPEX/Revenue US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| CAPEX/Revenue, % | 10.1% | 0.76% | 2.16% | 3.48% | 4.70% | 0.66% | |||
| Changes by years, y/y, % | -11pp | -9pp | +1pp | +1pp | +1pp | -26.0% | |||
AnaptysBio. CAPEX/Revenue, %
AnaptysBio. CAPEX/Revenue, changes, pp
AnaptysBio (ANAB) CAPEX/Revenue US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| CAPEX/Revenue, % | 4.88% | 3.11% | 0.38% | 0.30% | 0.12% | 0.66% | ||
| Changes by years, y/y, % | +1pp | +1pp | -12pp | -5pp | -5pp | |||
| Changes by quarters, q/q, % | -1pp | -2pp | -3pp | 0pp | 0pp | |||
